OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep’s lead program is an investigational, multi-peptide therapeutic vaccine being evaluated in treating smoldering multiple myeloma.
Contributions
Contributors
Contributions
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
